PubMed COVID-19 Clinical Care

The real-world vaccine protection rates (VPRs) against the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) infection are critical in formulating future vaccination strategies against the virus. Based on a varying coefficient stochastic

With the launch of Open AI's GPT-3 model in June 2020 came a new era for conversational chatbots (Open AI, n.d.). While there are chatbots who do not use AI, conversational chatbots integrate AI language models that allow for back-and-forth

The COVID-19 pandemic has introduced new norms, such as social distancing, face masks, quarantine, lockdowns, travel restrictions, work/study from home, and business closures, to name a few. The pandemic's seriousness has made people vocal on social

CONCLUSION: Health anxiety remained stable, with no significant change observed between the pre-pandemic period and the first 2 years of the COVID-19 pandemic in an adult, working population in Norway.

As a chronic autoimmune disease, systemic lupus erythematosus (SLE) primarily affects young women and does not discriminate against any particular organs. In December 2019, coronavirus disease 2019 (COVID-19) spread worldwide, with many speculations

We report the results of an experiment on willful information avoidance regarding measures to address Covid-19. In the experiment, participants choose between two options, each associated with a contribution to the Corona Fund of the Red Cross USA

The novel human coronavirus, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), which results in the coronavirus disease 2019 (COVID-19), has caused a serious threat to global public health. Therefore, many studies are performed on the

CONCLUSION: Differential attainment profiles varied 17-fold, yet COVID-19 did not influence ARCPO or MRCS pass rates. NTN appointment fell by one fifth peri-COVID, but overall training outcome metrics remained robust despite the existential threat.

Understanding consequences of the COVID-19 pandemic requires information on the excess mortality resulting from it. Multiple studies have examined excess deaths during the pandemic's initial stages, but how these have changed over time is unclear

This study aims to report analyses regarding the global distribution of institutions involved in clinical trials of COVID-19 vaccines throughout February 2022. We retrieved global data from the World Health Organization report on vaccine development